Lanka Realty Investments Balans Gezondheid

Financiële gezondheid criteriumcontroles 0/6

Lanka Realty Investments has a total shareholder equity of LKR9.6B and total debt of LKR4.7B, which brings its debt-to-equity ratio to 48.8%. Its total assets and total liabilities are LKR18.5B and LKR9.0B respectively.

Belangrijke informatie

48.8%

Verhouding schuld/eigen vermogen

LK₨4.67b

Schuld

Rente dekkingsratio	n/a
Contant	LK₨243.73m
Aandelen	LK₨9.57b
Totaal verplichtingen	LK₨8.97b
Totaal activa	LK₨18.54b

Recente financiële gezondheidsupdates

Geen updates

Recent updates

Analyse van de financiële positie

Kortlopende schulden: ASCO.N0000's short term assets (LKR1.2B) do not cover its short term liabilities (LKR2.9B).

Langlopende schulden: ASCO.N0000's short term assets (LKR1.2B) do not cover its long term liabilities (LKR6.0B).

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: ASCO.N0000's net debt to equity ratio (46.3%) is considered high.

Schuld verminderen: ASCO.N0000's debt to equity ratio has increased from 3.9% to 48.8% over the past 5 years.

Schuldendekking: ASCO.N0000's debt is not well covered by operating cash flow (2.7%).

Rentedekking: Insufficient data to determine if ASCO.N0000's interest payments on its debt are well covered by EBIT.

Lanka Realty Investments Balans Gezondheid

Financiële gezondheid criteriumcontroles 0/6

Belangrijke informatie

Recente financiële gezondheidsupdates

Recent updates

New major risk - Revenue and earnings growth

Lanka Realty Investments PLC, Annual General Meeting, Sep 27, 2024

Full year 2024 earnings released: LK₨0.66 loss per share (vs LK₨4.98 loss in FY 2023)

Third quarter 2024 earnings released: LK₨0.72 loss per share (vs LK₨3.38 loss in 3Q 2023)

New minor risk - Share price stability

Second quarter 2024 earnings released: LK₨0.67 loss per share (vs LK₨1.16 loss in 2Q 2023)

Lanka Realty Investments PLC, Annual General Meeting, Sep 21, 2023

New minor risk - Revenue size

First quarter 2024 earnings released: LK₨0.68 loss per share (vs LK₨1.21 loss in 1Q 2023)

Full year 2023 earnings released: LK₨5.00 loss per share (vs LK₨4.54 profit in FY 2022)

Executive Director recently sold LK₨923k worth of stock

Executive Director recently sold LK₨1.0m worth of stock

Third quarter 2023 earnings released: LK₨3.38 loss per share (vs LK₨0.04 loss in 3Q 2022)

Investor sentiment deteriorated over the past week

Executive Director recently bought LK₨389k worth of stock

Executive Director recently bought LK₨1.2m worth of stock

Investor sentiment improved over the past week

Executive Director recently bought LK₨1.1m worth of stock

Less than half of directors are independent

Second quarter 2023 earnings released

First quarter 2023 earnings released: LK₨1.22 loss per share (vs LK₨0.34 loss in 1Q 2022)

Full year 2022 earnings released: EPS: LK₨5.55 (vs LK₨1.02 loss in FY 2021)

Executive Director recently bought LK₨885k worth of stock

Less than half of directors are independent

Executive Director recently bought LK₨622k worth of stock

Executive Director recently bought LK₨988k worth of stock

Executive Director recently bought LK₨246m worth of stock

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Non-Executive Director recently sold LK₨740m worth of stock

Second quarter 2022 earnings released: LK₨0.28 loss per share (vs LK₨0.42 loss in 2Q 2021)

Full year 2021 earnings released: LK₨0.76 loss per share (vs LK₨4.49 profit in FY 2020)

New 90-day low: LK₨33.00

Third quarter 2021 earnings released: LK₨0.33 loss per share (vs LK₨2.38 profit in 3Q 2020)

New 90-day high: LK₨39.80

First half earnings released

New 90-day low: LK₨32.80

New 90-day high: LK₨40.40

New 90-day low - LK₨33.20

Analyse van de financiële positie

Schuld/ eigen vermogen geschiedenis en analyse

Balans

Ontdek gezonde bedrijven